Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Veterinary Medical Science|June 8, 2006
Prevention of immune responses to human erythropoietin in cynomolgus monkeys (Macaca fascicularis)Naohide Ageyama, Yutaka Hanazono, Hiroaki Shibata, et al.
Plos One|January 9, 2015
Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosisDaisuke Mizokami, Koji Araki, Nobuaki Tanaka, et al.
Head & Neck|April 11, 2019
Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase-specific oncolytic Sendai virusYoshihiro Miyagawa, Koji Araki, Taku Yamashita, et al.
Plos One|August 19, 2009
Cytokine-based log-scale expansion of functional murine dendritic cellsYui Harada, Yasuji Ueda, Hiroaki Kinoh, et al.
The Journal of Gene Medicine|September 11, 2002
Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primatesYutaka Hanazono, Keiji Terao, Hiroaki Shibata, et al.
Experimental Animals|December 21, 2005
Safe and efficient collection of cytokine-mobilized peripheral blood cells from cynomolgus monkeys (Macaca fascicularis) with human newborn-equivalent body weightsNaohide Ageyama, Yutaka Hanazono, Hiroaki Shibata, et al.
Cancer Science|July 21, 2015
Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cellsS M Rafiqul Islam, Yusuke Suenaga, Atsushi Takatori, et al.
Anticancer Research|November 3, 2004
VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivoYasuji Ueda, Takehiro Yamagishi, Hisao Ikeya, et al.
Scientific Reports|February 23, 2012
Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cellsYui Harada, Yae Okada-Nakanishi, Yasuji Ueda, et al.
Cancer Chemotherapy and Pharmacology|April 6, 2004
A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growthYasuji Ueda, Takehiro Yamagishi, Kazunori Samata, et al.
Pageof 5